Biotech China 2014

Biology: Bristol-Myers Squibb

Total Score People Score Events Score
20 19 17
Date Event Presentation Speakers
November 3, 2010 Eighth Annual RNAi for Functional Screens RNAi Screen With a High-Throughput qRT-PCR Assay Readout for Novel Target Identification Namjin Chung
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit 1 Key Factors to be Considered for Clinical Development in Emerging Markets Ruiping Dong
1 Chairperson's Opening Remarks Ruiping Dong
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety The Challenges of Predicting Metabolism-Mediated Toxicity In Vitro Frederic Moulin
June 9, 2009 RNAi for Target Identification and Validation Use of RNAi Screens with Physiologically Relevant Cell Models to Identify Novel Therapeutic Targets Namjin Chung
February 9, 2009 Immunogenicity for Biologics 2009 Challenge to establish proper confirmatory assay cut point Dong Geng
January 26, 2009 7th Annual Partnering with Central Labs Track A : Risk Management for Global Studies Raphaële Mary
Track B : Imaging Regulatory Environment Shift Strategies Beth Sabatino
December 7, 2008 Antibody Engineering k-ras Mutations and Response to Cetuximab Treatment David J Mauro
October 22, 2008 Targeting Diabetes With Novel Therapeutics SGLT2 Inhibition: A Novel Approach to the Treatment of Type 2 Diabetes Jean Whaley
September 29, 2008 Genomic Biomarkers Discovery of Gene Expression-Based Pharmacodynamic Biomarkers in Tumor Immunotherapies Zenta Tsuchihashi
May 30, 2008 ASCO Annual'08 Meeting clinical trials-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
clinical trials-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
international-- Choice of Comparator in Pivotal Phase III Clinical Trials: Clinical Versus Regulatory Standard of Care Steven D. Averbuch
tumor biology-- Endpoints for Immunotherapy Studies: Design and Regulatory Implications Axel Hoos
December 1, 2007 47TH American Socieity of Cell Biology Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Lois Burton
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi FOR IN VIVO TARGET VALIDATION: Validation of Drug Targets Through in vivo Application of siRNA Oligonucleotides (16:30-17:00) Siew Ho
RNAi FOR IN VIVO TARGET VALIDATION (16:30-19:30) Siew Ho
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SELECTING LEADS AND DETECTING ADVERSE ACTIVITY: Characterizing the Multiple Activities of Kinase Inhibitors (15:05-15:35) Petra Ross-Macdonald
SELECTING LEADS AND DETECTING ADVERSE ACTIVITY (14:00-17:30) Petra Ross-Macdonald
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third annual Genomic Biomarkers: PHARMACOGENETICS: Changing the Benefit/Risk Profile Using Pharmacogenetics (09:05-09:35) Koustubh Ranade
Third annual Genomic Biomarkers: PHARMACOGENETICS (08:30-11:30) Koustubh Ranade
Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS: Discovery and Validation of Biomarkers Affected by Brivanib and Erbitux (11:30-12:00) J. Suso Platero
Third annual Genomic Biomarkers: VALIDATION OF GENOMIC BIOMARKERS (11:30-14:00) J. Suso Platero
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities Interactive Panel Discussion#3 (11:30-12:15) Balu Balasubramanian
August 4, 2007 Glucose Transporter Biology Regulation of GLUT4 trafficking via PKB-dependent Jeremy Tavaré
June 2, 2007 Proteases in Hemostasis and Vascular Biology SMALL MOLECULE COAGULATION PROTEASE INHIBITORS - FROM BENCH TOP TO BEDSIDE Robert M Knabb
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.